Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus
- Author:
Ying-Guat OOI
1
;
Tharsini SARVANANDAN
;
Nicholas Ken Yoong HEE
;
Quan-Hziung LIM
;
Sharmila S. PARAMASIVAM
;
Jeyakantha RATNASINGAM
;
Shireene R. VETHAKKAN
;
Soo-Kun LIM
;
Lee-Ling LIM
Author Information
- Publication Type:Review
- From:Diabetes & Metabolism Journal 2024;48(2):196-207
- CountryRepublic of Korea
- Language:EN
- Abstract: People with type 2 diabetes mellitus have increased risk of chronic kidney disease and atherosclerotic cardiovascular disease. Improved care delivery and implementation of guideline-directed medical therapy have contributed to the declining incidence of atherosclerotic cardiovascular disease in high-income countries. By contrast, the global incidence of chronic kidney disease and associated mortality is either plateaued or increased, leading to escalating direct and indirect medical costs. Given limited resources, better risk stratification approaches to identify people at risk of rapid progression to end-stage kidney disease can reduce therapeutic inertia, facilitate timely interventions and identify the need for early nephrologist referral. Among people with chronic kidney disease G3a and beyond, the kidney failure risk equations (KFRE) have been externally validated and outperformed other risk prediction models. The KFRE can also guide the timing of preparation for kidney replacement therapy with improved healthcare resources planning and may prevent multiple complications and premature mortality among people with chronic kidney disease with and without type 2 diabetes mellitus. The present review summarizes the evidence of KFRE to date and call for future research to validate and evaluate its impact on cardiovascular and mortality outcomes, as well as healthcare resource utilization in multiethnic populations and different healthcare settings.
